Literature DB >> 12750763

New therapeutic approaches to the treatment of nasal allergy: Antiinflammatory effects of H(1) receptor antagonists.

Terumichi Fujikura1.   

Abstract

Histamine is recognized as an important mediator of allergic rhinitis. In addition to the role it plays in the immediate-phase reaction of nasal allergy, histamine may play an important role in the late-phase reaction and protracted allergic inflammation. Histamine induces the synthesis or secretion of proinflammatory cytokines and the expression of adhesion molecules. Besides their traditional effects via H(1) receptor antagonism, antihistamines have been reported to possess multiple antiinflammatory effects. Continuous use of antihistamines may reduce the level of minimal persistent inflammation of nasal mucosa in allergy. Treatment of allergic rhinitis using antihistamines could contribute to the improvement in coexisting allergic inflammation of the lower airways. (c) 2001 Prous Science. All rights reserved.

Entities:  

Year:  2001        PMID: 12750763     DOI: 10.1358/dot.2001.37.7.844188

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  2 in total

1.  Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration.

Authors:  Friedrich Horak; Petra U Zieglmayer; R Zieglmayer; A Kavina; P Lemell
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

Review 2.  Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies.

Authors:  G W Canonica; E Compalati
Journal:  Clin Exp Immunol       Date:  2009-08-25       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.